Literature DB >> 24234308

A comparison of two approaches to education about carrier testing for cystic fibrosis.

K P Leonard1, L K Bartholomew, P R Swank, G S Parcel.   

Abstract

We tested the efficacy of two types of educational materials for genetic counseling: a traditional information brochure and one adding a role model story. Brochures were alternated weekly at a prenatal genetics center. Subjects were asked to read the brochure and fill out a questionnaire covering demographics and variables from the health belief model (impact, barriers, motivation, susceptibility, knowledge, severity). A group of 409 pregnant women and 251 male partners participated. Study design was quasiexperimental, using a post-test only comparison group. The brochure with modeling enhanced the perception of both risk and the severity of the disease and was inversely associated with the assessment of barriers, but did not directly impact on the decision to pursue testing; only 12% chose to be tested, with no significant differences between groups. While suggestive, the study is not confirmatory and should be repeated with a more heterogenous group of women.

Entities:  

Year:  1995        PMID: 24234308     DOI: 10.1007/BF01408633

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  23 in total

1.  Cystic fibrosis carrier screening at first diagnosis of pregnancy in general practice.

Authors:  H J Harris; D Scotcher; D Craufurd; A Wallace; R Harris
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

2.  Statement of the American Society of Human Genetics on cystic fibrosis carrier screening.

Authors: 
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

3.  Principles and practicalities of carrier screening: attitudes of recent parents.

Authors:  J M Green
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

4.  Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families.

Authors:  D C Wertz; S R Janes; J M Rosenfield; R W Erbe
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

5.  Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis.

Authors:  M Decruyenaere; G Evers-Kiebooms; L Denayer; H Van den Berghe
Journal:  Clin Genet       Date:  1992-04       Impact factor: 4.438

6.  Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.

Authors:  M E Mennie; W A Liston; D J Brock
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

7.  Patients' subjective interpretation of risks offered in genetic counselling.

Authors:  J H Pearn
Journal:  J Med Genet       Date:  1973-06       Impact factor: 6.318

8.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  The prevention of thalassemia in Sardinia.

Authors:  A Cao; C Rosatelli; R Galanello; G Monni; G Olla; P Cossu; M S Ristaldi
Journal:  Clin Genet       Date:  1989-11       Impact factor: 4.438

10.  Prenatal screening for hemoglobinopathies. I. A prospective regional trial.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more
  2 in total

Review 1.  How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.

Authors:  Stephanie Sivell; Glyn Elwyn; Clara L Gaff; Angus J Clarke; Rachel Iredale; Chris Shaw; Joanna Dundon; Hazel Thornton; Adrian Edwards
Journal:  J Genet Couns       Date:  2007-10-30       Impact factor: 2.537

2.  Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales.

Authors:  Nadine A Kasparian; Claire E Wakefield; Bettina Meiser
Journal:  J Genet Couns       Date:  2007-08-13       Impact factor: 2.537

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.